Latest News

Filters

Filter by tags: Radiopharmaceutical Canada Clear all tag filters

5 news articles found


Canadian Nuclear Laboratories (CNL) is to collaborate with US-based Jubilant Radiopharma to develop alpha radiopharmaceuticals. The joint project comes under CNL’s Canadian Nuclear Research Initiative -Health (CNRI-H) programme. It is part of a broader CNL effort to develop radiopharmaceutical therapies using Actinium-225, a medical isotope produced by CNL.

Date: Wednesday, 08 February 2023
Original article: neimagazine.com/news/newscnl-and-jubilant-radiopharma-collaborate-on-actinium-225-10574940

Lutetium-177 (Lu-177) has been produced using a new isotope production system (IPS) that was installed in unit 7 of the Bruce plant in Ontario, Canada, during a recent planned maintenance outage. It marks the first time the short-lived medical isotope has been produced in a commercial nuclear power reactor.

Date: Thursday, 23 June 2022
Original article: world-nuclear-news.org/Articles/Canadian-Candu-produces-cancer-therapy-isotope

ARTMS, a Canadian producer of medical isotopes has registered the cyclotron production of gallium-68 with the government of Canada, filing a Type 1 Master File with the Health Products & Food Branch of Health Canada.

Date: Thursday, 28 October 2021
Original article: neimagazine.com/news/newscanadas-artms-registers-cyclotron-production-of-gallium-68-9189609

Three recent announcements will help secure future supplies of vital medical radioisotopes. Westinghouse Electric Company and Nordion (Canada) Inc are to work together on technology to produce cobalt-60 in pressurised water reactors (PWRs); Framatome and Kinectrics have launched a new joint venture to produce lutetium-177 in partnership with Bruce Power; and BWXT Technologies' proprietary technetium-99m generators have passed a testing milestone.

Date: Saturday, 29 February 2020
Original article: world-nuclear-news.org/Articles/Companies-work-on-securing-medical-isotope-supplie

Status

No Tags found.